inner-banner-bg

Journal of Clinical & Experimental Immunology(JCEI)

ISSN: 2475-6296 | DOI: 10.33140/JCEI

Impact Factor: 1.9

Therapeutic Monoclonal Antibodies Approved by FDA in 2022

Citation

Henry Hongrong Cai and Ayesha A. Pandit

Henry Hongrong Cai and Ayesha A. Pandit. (2023). Therapeutic monoclonal antibodies approved by FDA in 2022 (mini review). J Clin Exp Immunol. 8(1); 533-535.

Abstract PDF